Dopaminergic and norepinephrinergic modulation of endogenous event-related potentials: A systematic review and meta-analysis

[1]  N. Swerdlow,et al.  EEG reveals that dextroamphetamine improves cognitive control through multiple processes in healthy participants , 2022, Neuropsychopharmacology.

[2]  Penny A. MacDonald,et al.  Null effects of levodopa on reward- and error-based motor adaptation, savings, and anterograde interference. , 2021, Journal of neurophysiology.

[3]  R. Daniels,et al.  Classics in Chemical Neuroscience: Amitriptyline. , 2021, ACS chemical neuroscience.

[4]  A. Sheikhani,et al.  Interval‐based features of auditory ERPs for diagnosis of early Alzheimer's disease , 2021, Alzheimer's & dementia.

[5]  V. Roessner,et al.  Task experience eliminates catecholaminergic effects on inhibitory control – A randomized, double-blind cross-over neurophysiological study , 2020, European Neuropsychopharmacology.

[6]  J. Kenemans,et al.  Dopaminergic and noradrenergic manipulation of anticipatory reward and probability event-related potentials , 2020, Psychopharmacology.

[7]  L. Colzato,et al.  A literature review on the neurophysiological underpinnings and cognitive effects of transcutaneous vagus nerve stimulation: challenges and future directions. , 2020, Journal of neurophysiology.

[8]  J. Kenemans,et al.  A frontal-vagal network theory for Major Depressive Disorder: Implications for optimizing neuromodulation techniques , 2020, Brain Stimulation.

[9]  A. Broncel,et al.  Vagal nerve stimulation as a promising tool in the improvement of cognitive disorders , 2019, Brain Research Bulletin.

[10]  T. Handy,et al.  Variability in Executive Control Performance Is Predicted by Physical Activity , 2020, Frontiers in Human Neuroscience.

[11]  P. Bollu,et al.  Neurobiology of ADHD: A Review , 2019, Current Developmental Disorders Reports.

[12]  F. Fregni,et al.  S-Ketamine’s Effect Changes the Cortical Electrophysiological Activity Related to Semantic Affective Dimension of Pain: A Placebo- Controlled Study in Healthy Male Individuals , 2019, Front. Neurosci..

[13]  Christine M. Madla,et al.  The mechanisms of pharmacokinetic food-drug interactions - A perspective from the UNGAP group. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[14]  S. Nieuwenhuis,et al.  The neuromodulatory and hormonal effects of transcutaneous vagus nerve stimulation as evidenced by salivary alpha amylase, salivary cortisol, pupil diameter, and the P3 event-related potential , 2019, Brain Stimulation.

[15]  Méadhbh B. Brosnan,et al.  Catecholamine Modulation of Evidence Accumulation during Perceptual Decision Formation: A Randomized Trial , 2019, Journal of Cognitive Neuroscience.

[16]  C. Stagg,et al.  Catecholaminergic modulation of indices of cognitive flexibility: A pharmaco-tDCS study , 2019, Brain Stimulation.

[17]  Carlo Lai,et al.  Neurophysiological correlate of emotional regulation in cognitive and motor deficits in Tourette’s syndrome , 2019, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[18]  Nitin B. Bangera,et al.  Exploration of the Impact of Brief Noninvasive Vagal Nerve Stimulation on EEG and Event‐Related Potentials , 2018, Neuromodulation : journal of the International Neuromodulation Society.

[19]  B. Kopp,et al.  Executive dysfunction in Parkinson’s disease: A meta-analysis on the Wisconsin Card Sorting Test literature , 2018, Neuroscience & Biobehavioral Reviews.

[20]  H. Heinze,et al.  Modulating auditory selective attention by non‐invasive brain stimulation: Differential effects of transcutaneous vagal nerve stimulation and transcranial random noise stimulation , 2018, The European journal of neuroscience.

[21]  Shu-Chen Li,et al.  The system‐neurophysiological basis for how methylphenidate modulates perceptual–attentional conflicts during auditory processing , 2018, Human brain mapping.

[22]  Sander Nieuwenhuis,et al.  Noradrenergic and Cholinergic Modulation of Belief Updating , 2018, Journal of Cognitive Neuroscience.

[23]  V. Roessner,et al.  Catecholaminergic Modulation of Conflict Control Depends on the Source of Conflicts , 2018, The international journal of neuropsychopharmacology.

[24]  A. Hamm,et al.  Effects of Transcutaneous Vagus Nerve Stimulation (tVNS) on the P300 and Alpha-Amylase Level: A Pilot Study , 2018, Front. Hum. Neurosci..

[25]  M. Coll.  Meta-analysis of ERP investigations of pain empathy underlines methodological issues in ERP research , 2018, bioRxiv.

[26]  A. Hamm,et al.  Transcutaneous vagus nerve stimulation (tVNS) enhances conflict-triggered adjustment of cognitive control , 2018, Cognitive, Affective, & Behavioral Neuroscience.

[27]  N. Costes,et al.  Frontal Transcranial Direct Current Stimulation Induces Dopamine Release in the Ventral Striatum in Human , 2018, Cerebral cortex.

[28]  C. Beste,et al.  Tics and Tourette syndrome — surplus of actions rather than disorder? , 2018, Movement disorders : official journal of the Movement Disorder Society.

[29]  U. Nater,et al.  Reliability and robustness of feedback-evoked brain-heart coupling after placebo, dopamine, and noradrenaline challenge. , 2018, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[30]  Gabor Stefanics,et al.  EEG and ERP biomarkers of Alzheimer's disease: a critical review. , 2018, Frontiers in bioscience.

[31]  S. Kelly,et al.  The Effects of Methylphenidate on the Neural Signatures of Sustained Attention , 2017, Biological Psychiatry.

[32]  N. Swerdlow,et al.  Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors , 2017, The international journal of neuropsychopharmacology.

[33]  Belinda Pletzer,et al.  Interactive Effects of Dopamine Baseline Levels and Cycle Phase on Executive Functions: The Role of Progesterone , 2017, Front. Neurosci..

[34]  Sarah E. Forster,et al.  Event-related potentials reflect impaired temporal interval learning following haloperidol administration , 2017, Psychopharmacology.

[35]  A. Strobel,et al.  Genetic variation of dopamine and serotonin function modulates the feedback-related negativity during altruistic punishment , 2017, Scientific Reports.

[36]  Ruud L. van den Brink,et al.  Norepinephrine transporter blocker atomoxetine increases salivary alpha amylase , 2017, Psychoneuroendocrinology.

[37]  Н. Л. Векшина,et al.  Гетеромерные комплексы D1-D2-дофаминовых рецепторов: обзор литературных данных , 2017 .

[38]  Nicholas Gaspelin,et al.  How to get statistically significant effects in any ERP experiment (and why you shouldn't). , 2017, Psychophysiology.

[39]  B. Kopp,et al.  Event-related potentials and cognition in Parkinson’s disease: An integrative review , 2016, Neuroscience & Biobehavioral Reviews.

[40]  Matthew R. Nassar,et al.  Catecholaminergic Regulation of Learning Rate in a Dynamic Environment , 2016, PLoS Comput. Biol..

[41]  Robert J. Barry,et al.  Reinstating the Novelty P3 , 2016, Scientific Reports.

[42]  H. Hoijtink,et al.  P300 amplitude variations, prior probabilities, and likelihoods: A Bayesian ERP study , 2016, Cognitive, affective & behavioral neuroscience.

[43]  B. Franke,et al.  Opposite effects of cannabis and cocaine on performance monitoring , 2016, European Neuropsychopharmacology.

[44]  C. Beste,et al.  Dissociable electrophysiological subprocesses during response inhibition are differentially modulated by dopamine D1 and D2 receptors , 2016, European Neuropsychopharmacology.

[45]  Antao Chen,et al.  Different relationships between central dopamine system and sub-processes of inhibition: Spontaneous eye blink rate relates with N2 but not P3 in a Go/Nogo task , 2016, Brain and Cognition.

[46]  E. Huang,et al.  Dopaminergic Neurons and Brain Reward Pathways: From Neurogenesis to Circuit Assembly. , 2016, The American journal of pathology.

[47]  Grace Y. Wang,et al.  Acute effects of BZP, TFMPP and the combination of BZP and TFMPP in comparison to dexamphetamine on an auditory oddball task using electroencephalography: a single-dose study , 2016, Psychopharmacology.

[48]  Hiroshi Yamada,et al.  Roles of the Lateral Habenula and Anterior Cingulate Cortex in Negative Outcome Monitoring and Behavioral Adjustment in Nonhuman Primates , 2015, Neuron.

[49]  Sander Nieuwenhuis,et al.  Transcutaneous Vagus Nerve Stimulation Enhances Post-error Slowing , 2015, Journal of Cognitive Neuroscience.

[50]  Stephen B. R. E. Brown,et al.  Effects of clonidine and scopolamine on multiple target detection in rapid serial visual presentation , 2015, Psychopharmacology.

[51]  Peter E. Clayson,et al.  The Effects of Acute Dopamine Precursor Depletion on the Cognitive Control Functions of Performance Monitoring and Conflict Processing: An Event-Related Potential (ERP) Study , 2015, PloS one.

[52]  Sander Nieuwenhuis,et al.  Noradrenergic and cholinergic modulation of late ERP responses to deviant stimuli. , 2015, Psychophysiology.

[53]  Yuping Wang,et al.  Effect of methylphenidate on mismatched visual information processing in young healthy volunteers: an event-related potential study. , 2015, International journal of clinical and experimental medicine.

[54]  L. Colzato,et al.  Transcutaneous vagus nerve stimulation (tVNS) enhances response selection during action cascading processes , 2015, European Neuropsychopharmacology.

[55]  W-J Huang,et al.  The neurophysiology of P 300--an integrated review. , 2015, European review for medical and pharmacological sciences.

[56]  W. McMahon,et al.  Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. , 2015, JAMA psychiatry.

[57]  M. Carabotti,et al.  The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems , 2015, Annals of gastroenterology.

[58]  Florian Lange,et al.  Dual routes to cortical orienting responses: Novelty detection and uncertainty reduction , 2015, Biological Psychology.

[59]  M. Botvinick,et al.  Motivation and cognitive control: from behavior to neural mechanism. , 2015, Annual review of psychology.

[60]  P. Baud,et al.  DAT1 and DRD4 genes involved in key dimensions of adult ADHD , 2015, Neurological Sciences.

[61]  B. Waterhouse,et al.  New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons , 2014, Front. Neural Circuits.

[62]  R. Verkes,et al.  The acute effects of MDMA and ethanol administration on electrophysiological correlates of performance monitoring in healthy volunteers , 2014, Psychopharmacology.

[63]  E. Vuurman,et al.  Cognitive effects of methylphenidate and levodopa in healthy volunteers , 2014, European Neuropsychopharmacology.

[64]  D. Veltman,et al.  Systematic review of ERP and fMRI studies investigating inhibitory control and error processing in people with substance dependence and behavioural addictions. , 2014, Journal of psychiatry & neuroscience : JPN.

[65]  J. Hensler,et al.  Catecholamine/Serotonin interactions: systems thinking for brain function and disease. , 2013, Advances in pharmacology.

[66]  U. Panjwani,et al.  Tyrosine ameliorates heat induced delay in event related potential P300 and contingent negative variation , 2013, Brain and Cognition.

[67]  N. Bohnen,et al.  Dopamine overdose hypothesis: Evidence and clinical implications , 2013, Movement disorders : official journal of the Movement Disorder Society.

[68]  J. Leon Kenemans,et al.  The effect of noradrenergic attenuation by clonidine on inhibition in the stop signal task , 2013, Pharmacology Biochemistry and Behavior.

[69]  L. Kiss,et al.  CHAPTER 4:Catechol‐O‐Methyl‐Transferase Inhibitors: Present Problems and Relevance of the New Ones , 2013 .

[70]  B. Kopp,et al.  Electrophysiological indicators of surprise and entropy in dynamic task-switching environments , 2013, Front. Hum. Neurosci..

[71]  Therese van Amelsvoort,et al.  The Detection of Novelty Relies on Dopaminergic Signaling: Evidence from Apomorphine's Impact on the Novelty N2 , 2013, PloS one.

[72]  J. Debruille,et al.  Effects of a small dose of olanzapine on healthy subjects according to their schizotypy: An ERP study using a semantic categorization and an oddball task , 2013, European Neuropsychopharmacology.

[73]  R. O’Connell,et al.  Monoaminergic modulation of behavioural and electrophysiological indices of error processing , 2013, Psychopharmacology.

[74]  Adam Gazzaley,et al.  A cognitive framework for understanding and improving interference resolution in the brain. , 2013, Progress in brain research.

[75]  G. Price,et al.  Dexamphetamine reduces auditory P3 delta power and phase-locking while increasing gamma power , 2012, European Neuropsychopharmacology.

[76]  H. Snieder,et al.  Clinical response to antipsychotic drug treatment: Association study of polymorphisms in six candidate genes , 2012, European Neuropsychopharmacology.

[77]  L. Peltonen,et al.  Sex-specific influence of DRD2 on ADHD-type temperament in a large population-based birth cohort , 2012, Psychiatric genetics.

[78]  Carsten Lukas,et al.  Mechanisms mediating parallel action monitoring in fronto-striatal circuits , 2012, NeuroImage.

[79]  Gary Aston-Jones,et al.  The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease , 2012, Front. Behav. Neurosci..

[80]  J. Kenemans,et al.  Genetic polymorphisms of the dopamine and serotonin systems modulate the neurophysiological response to feedback and risk taking in healthy humans , 2012, Cognitive, affective & behavioral neuroscience.

[81]  T. Demiralp,et al.  Cognitive evaluation of bupropion sustained release in heavy tobacco smokers using event-related potentials. , 2012, Medicina.

[82]  Dan J Stein,et al.  Synergistic tonic and phasic activity of the locus coeruleus norepinephrine (LC-NE) arousal system is required for optimal attentional performance , 2012, Metabolic Brain Disease.

[83]  Y. Zou,et al.  Association of DRD2 gene polymorphisms with mood disorders: a meta-analysis. , 2012, Journal of affective disorders.

[84]  William J. Gehring,et al.  The Error-Related Negativity (ERN/Ne) , 2011 .

[85]  G. Price,et al.  Dexamphetamine-induced reduction of P3a and P3b in healthy participants , 2011, Journal of psychopharmacology.

[86]  R. O’Connell,et al.  Pupillometry and P3 index the locus coeruleus-noradrenergic arousal function in humans. , 2011, Psychophysiology.

[87]  Sander Nieuwenhuis,et al.  Learning, the P3, and the Locus Coeruleus-Norepinephrine System , 2011 .

[88]  Tracy Warbrick,et al.  Ketamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task , 2011, NeuroImage.

[89]  W. Sommer,et al.  Residue iteration decomposition (RIDE): A new method to separate ERP components on the basis of latency variability in single trials. , 2011, Psychophysiology.

[90]  V. Knott,et al.  Separate and combined effects of low dose ketamine and nicotine on behavioural and neural correlates of sustained attention , 2011, Biological Psychology.

[91]  G. Juckel,et al.  Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential , 2011, Neuroscience Letters.

[92]  Penny A. MacDonald,et al.  Differential Effects of Dopaminergic Therapies on Dorsal and Ventral Striatum in Parkinson's Disease: Implications for Cognitive Function , 2011, Parkinson's Disease.

[93]  A. Cavanna,et al.  Impulse Control Disorders Following Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease: Clinical Aspects , 2011, Parkinson's disease.

[94]  F. Horak,et al.  Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. , 2011, Archives of neurology.

[95]  W. Riedel,et al.  Effects of tyrosine/phenylalanine depletion on electrophysiological correlates of memory in healthy volunteers , 2011, Journal of psychopharmacology.

[96]  J Leon Kenemans,et al.  How Human Electrophysiology Informs Psychopharmacology: from Bottom-up Driven Processing to Top-Down Control , 2011, Neuropsychopharmacology.

[97]  C. C. Duncan,et al.  Brain potential indices of novelty processing are associated with preference for amphetamine. , 2010, Experimental and clinical psychopharmacology.

[98]  Hartmut Heinrich,et al.  ERP effects of methylphenidate and working memory load in healthy adults during a serial visual working memory task , 2010, Neuroscience Letters.

[99]  P. Ruitenbeek,et al.  Memory in humans is unaffected by central H1-antagonism, while objectively and subjectively measured sedation is increased , 2010, European Neuropsychopharmacology.

[100]  K. Phan,et al.  Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants , 2010, Psychopharmacology.

[101]  Bob Oranje,et al.  Haloperidol counteracts the ketamine-induced disruption of processing negativity, but not that of the P300 amplitude. , 2009, The international journal of neuropsychopharmacology.

[102]  Michael J. Frank,et al.  Single dose of a dopamine agonist impairs reinforcement learning in humans: Evidence from event‐related potentials and computational modeling of striatal‐cortical function , 2009, Human brain mapping.

[103]  A. Malhotra,et al.  Acute dopamine depletion with branched chain amino acids decreases auditory top-down event-related potentials in healthy subjects , 2009, Schizophrenia Research.

[104]  M. Falkenstein,et al.  Error Processing in Normal Aging and in Basal Ganglia Disorders Experimental Procedures Participants Six Groups Were Enrolled into Study. a Group of 17 Medicated Patients with Pd Measured after Overnight Withdrawal off Their , 2022 .

[105]  R. Boellaard,et al.  Δ9-Tetrahydrocannabinol Induces Dopamine Release in the Human Striatum , 2009, Neuropsychopharmacology.

[106]  M. Falkenstein,et al.  Effects of stimulus–response compatibility on inhibitory processes in Parkinson’s disease , 2009, The European journal of neuroscience.

[107]  D. Stuss,et al.  Age-related differences in processing irrelevant information: Evidence from event-related potentials , 2009, Neuropsychologia.

[108]  V. Sinha,et al.  Event-related potential: An overview , 2009, Industrial psychiatry journal.

[109]  Shihui Han,et al.  Temporal dynamic of neural mechanisms involved in empathy for pain: An event-related brain potential study , 2008, Neuropsychologia.

[110]  A. Berney,et al.  Rapid Resolution of Dopamine Dysregulation Syndrome (DDS) After Subthalamic DBS for Parkinson Disease (PD): A Case Report , 2008, Cognitive and behavioral neurology : official journal of the Society for Behavioral and Cognitive Neurology.

[111]  G. Juckel,et al.  Effects of acute oral Δ9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers , 2008, European Neuropsychopharmacology.

[112]  Enea F Pavone,et al.  Electrophysiological correlates of crossmodal visual distractor congruency effects: Evidence for response conflict , 2008, Cognitive, affective & behavioral neuroscience.

[113]  Peter J. Snyder,et al.  Electroencephalography and event-related potentials as biomarkers of mild cognitive impairment and mild Alzheimer’s disease , 2008, Alzheimer's & Dementia.

[114]  Jonathan R. Folstein,et al.  Influence of cognitive control and mismatch on the N2 component of the ERP: a review. , 2007, Psychophysiology.

[115]  Sohita Dhillon,et al.  Bupropion , 2012, Drugs.

[116]  M. Reuter,et al.  Genetically Determined Differences in Learning from Errors , 2007, Science.

[117]  Michael X. Cohen,et al.  Dopamine gene predicts the brain's response to dopaminergic drug , 2007, The European journal of neuroscience.

[118]  F. Marrosu,et al.  Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain , 2007, Brain Research.

[119]  L. Jonkman,et al.  Methylphenidate improves deficient error evaluation in children with ADHD: An event-related brain potential study , 2007, Biological Psychology.

[120]  M. Sarter,et al.  Modulators in concert for cognition: Modulator interactions in the prefrontal cortex , 2007, Progress in Neurobiology.

[121]  J. Polich.  Updating P300: An integrative theory of P3a and P3b , 2007, Clinical Neurophysiology.

[122]  Joseph A. Gogos,et al.  Site-Specific Role of Catechol-O-Methyltransferase in Dopamine Overflow within Prefrontal Cortex and Dorsal Striatum , 2007, The Journal of Neuroscience.

[123]  T. Baldeweg,et al.  Acute dopamine D1 and D2 receptor stimulation does not modulate mismatch negativity (MMN) in healthy human subjects , 2007, Psychopharmacology.

[124]  Paolo Calabresi,et al.  Dopamine-mediated regulation of corticostriatal synaptic plasticity , 2007, Trends in Neurosciences.

[125]  C. Clark,et al.  An integrative approach to determine the best behavioral and biological markers of methylphenidate. , 2007, Journal of integrative neuroscience.

[126]  J. Jonides,et al.  Interference resolution: Insights from a meta-analysis of neuroimaging tasks , 2007, Cognitive, affective & behavioral neuroscience.

[127]  A. Arnsten,et al.  Adrenergic pharmacology and cognition: focus on the prefrontal cortex. , 2007, Pharmacology & therapeutics.

[128]  N. Fox,et al.  Variations of the flanker paradigm: Assessing selective attention in young children , 2007, Behavior research methods.

[129]  Jonathan D. Cohen,et al.  On the Control of Control: The Role of Dopamine in Regulating Prefrontal Function and Working Memory , 2007 .

[130]  H. Westenberg,et al.  No effects of l-dopa and bromocriptine on psychophysiological parameters of human selective attention , 2006, Journal of psychopharmacology.

[131]  W. Hulstijn,et al.  Effects of antipsychotic and antidepressant drugs on action monitoring in healthy volunteers , 2006, Brain Research.

[132]  Torsten Baldeweg,et al.  Impact of frontal white matter lesions on performance monitoring: ERP evidence for cortical disconnection. , 2006, Brain : a journal of neurology.

[133]  Herbert Roeyers,et al.  Event rate and event-related potentials in ADHD. , 2006, Journal of child psychology and psychiatry, and allied disciplines.

[134]  M. Borenstein,et al.  Publication Bias in Meta-Analysis , 2006 .

[135]  J. Polich,et al.  Neuropsychology and neuropharmacology of P3a and P3b. , 2006, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[136]  Vinod Menon,et al.  Where and When the Anterior Cingulate Cortex Modulates Attentional Response: Combined fMRI and ERP Evidence , 2006, Journal of Cognitive Neuroscience.

[137]  G. Winterer,et al.  Persistent dysfunctional frontal lobe activation in former smokers , 2006, Psychopharmacology.

[138]  J. Os,et al.  Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: A meta analysis , 2006, Schizophrenia Research.

[139]  G. Ordway,et al.  The norepinephrine transporter and its regulation , 2006, Journal of neurochemistry.

[140]  H. Heinze,et al.  The Dopaminergic Midbrain Participates in Human Episodic Memory Formation: Evidence from Genetic Imaging , 2006, The Journal of Neuroscience.

[141]  R. J. Doherty,et al.  Separation of the components of the late positive complex in an ERP dishabituation paradigm , 2005, Clinical Neurophysiology.

[142]  A. Rodríguez-Fornells,et al.  A neurophysiological study of the detrimental effects of alprazolam on human action monitoring. , 2005, Brain research. Cognitive brain research.

[143]  S. Erhardt,et al.  Activation of noradrenergic locus coeruleus neurons by clozapine and haloperidol: involvement of glutamatergic mechanisms. , 2005, The international journal of neuropsychopharmacology.

[144]  Jonathan D. Cohen,et al.  An integrative theory of locus coeruleus-norepinephrine function: adaptive gain and optimal performance. , 2005, Annual review of neuroscience.

[145]  Axel Mecklinger,et al.  Age differences in attentional control: an event-related potential approach. , 2005, Psychophysiology.

[146]  Jonathan D. Cohen,et al.  Decision making, the P3, and the locus coeruleus-norepinephrine system. , 2005, Psychological bulletin.

[147]  R. Bressan,et al.  The role of dopamine in reward and pleasure behaviour – review of data from preclinical research , 2005, Acta psychiatrica Scandinavica. Supplementum.

[148]  Antoni Rodríguez-Fornells,et al.  Noradrenergic Stimulation Enhances Human Action Monitoring , 2005, The Journal of Neuroscience.

[149]  E. Gordon,et al.  The dose-dependent effect of methylphenidate on performance, cognition and psychophysiology. , 2005, Journal of integrative neuroscience.

[150]  J. Salamone,et al.  Beyond the reward hypothesis: alternative functions of nucleus accumbens dopamine. , 2005, Current opinion in pharmacology.

[151]  F. Guillem,et al.  Gender differences in memory processing: Evidence from event-related potentials to faces , 2005, Brain and Cognition.

[152]  M. Iyo,et al.  Effects of a small dose of triazolam on P300 and resting EEG , 1996, Psychopharmacology.

[153]  Enoch Callaway,et al.  A low dose of subcutaneous nicotine improves information processing in non-smokers , 1994, Psychopharmacology.

[154]  Wouter Hulstijn,et al.  Altered Response Evaluation Monitoring of Late Responses After Administration of D-Amphetamine , 2005 .

[155]  T. Endrass,et al.  Error Awareness in a Saccade Countermanding Task , 2005 .

[156]  J. Leysen,et al.  Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors , 2005, Psychopharmacology.

[157]  T. Robbins,et al.  Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates , 2004, Neuroscience & Biobehavioral Reviews.

[158]  Jia Zhou.  Norepinephrine transporter inhibitors and their therapeutic potential. , 2004, Drugs of the future.

[159]  Jonathan D. Cohen,et al.  The neural basis of error detection: conflict monitoring and the error-related negativity. , 2004, Psychological review.

[160]  Yu-Feng Wang,et al.  Association of norepinephrine transporter gene with methylphenidate response. , 2004, Journal of the American Academy of Child and Adolescent Psychiatry.

[161]  R Bruyer,et al.  Human gender differences in an emotional visual oddball task: an event-related potentials study , 2004, Neuroscience Letters.

[162]  Paul D. Kieffaber,et al.  Haloperidol Impairs Learning and Error-related Negativity in Humans , 2004, Journal of Cognitive Neuroscience.

[163]  Juliana Yordanova,et al.  Parallel systems of error processing in the brain , 2004, NeuroImage.

[164]  Rainer Goebel,et al.  Attentional systems in target and distractor processing: a combined ERP and fMRI study , 2004, NeuroImage.

[165]  W. Hulstijn,et al.  Drug-induced stimulation and suppression of action monitoring in healthy volunteers , 2004, Psychopharmacology.

[166]  M. Lader,et al.  The effects of repeated doses of clomipramine and alprazolam on physiological, psychomotor and cognitive functions in normal subjects , 2004, European Journal of Clinical Pharmacology.

[167]  A. Bond,et al.  Comparative effects of a repeated dose regime of diazepam and buspirone on subjective ratings, psychological tests and the EEG , 2004, European Journal of Clinical Pharmacology.

[168]  E. Callaway,et al.  The effect of methylphenidate on information processing , 2004, Psychopharmacology.

[169]  R. Herning,et al.  Information processing components of the auditory event related potential are reduced by cocaine , 2004, Psychopharmacology.

[170]  Clay B. Holroyd,et al.  A note on the oddball N200 and the feedback ERN , 2004 .

[171]  N. Zahniser,et al.  Rapid regulation of dopamine transporter function by substrates, blockers and presynaptic receptor ligands. , 2003, European journal of pharmacology.

[172]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[173]  Daniel R Weinberger,et al.  Catechol O-Methyltransferase (COMT) mRNA Expression in the Dorsolateral Prefrontal Cortex of Patients with Schizophrenia , 2003, Neuropsychopharmacology.

[174]  G. Demakis,et al.  A meta-analytic review of the sensitivity of the Wisconsin Card Sorting Test to frontal and lateralized frontal brain damage. , 2003, Neuropsychology.

[175]  R. Barry,et al.  A review of electrophysiology in attention-deficit/hyperactivity disorder: II. Event-related potentials , 2003, Clinical Neurophysiology.

[176]  S. Stahl.  Neurotransmission of cognition, part 2. Selective NRIs are smart drugs: exploiting regionally selective actions on both dopamine and norepinephrine to enhance cognition. , 2003, The Journal of clinical psychiatry.

[177]  B. Lipska,et al.  Catechol O-methyltransferase mRNA expression in human and rat brain: evidence for a role in cortical neuronal function , 2003, Neuroscience.

[178]  J. Polich.  Theoretical Overview of P3a and P3b , 2003 .

[179]  Jyrki Ahveninen,et al.  Dopamine modulates involuntary attention shifting and reorienting: an electromagnetic study , 2002, Clinical Neurophysiology.

[180]  C. Carter,et al.  The anterior cingulate as a conflict monitor: fMRI and ERP studies , 2002, Physiology & Behavior.

[181]  Patrizia Rizzu,et al.  Mutations in the DJ-1 Gene Associated with Autosomal Recessive Early-Onset Parkinsonism , 2002, Science.

[182]  Clay B. Holroyd,et al.  The neural basis of human error processing: reinforcement learning, dopamine, and the error-related negativity. , 2002, Psychological review.

[183]  B. Kopp,et al.  Brain mechanisms of visual encoding and working memory in psychometrically identified schizotypal individuals and after acute administration of haloperidol. , 2002, Psychophysiology.

[184]  J. Kenemans,et al.  Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory , 2002, Psychopharmacology.

[185]  Eddy J. Davelaar,et al.  Neuromodulation of decision and response selection , 2002, Neural Networks.

[186]  C. Carter,et al.  The Timing of Action-Monitoring Processes in the Anterior Cingulate Cortex , 2002, Journal of Cognitive Neuroscience.

[187]  B. Turetsky,et al.  Alpha2-noradrenergic effects on ERP and behavioral indices of auditory information processing. , 2002, Psychophysiology.

[188]  K. R. Ridderinkhof,et al.  A computational account of altered error processing in older age: Dopamine and the error-related negativity , 2002, Cognitive, affective & behavioral neuroscience.

[189]  H. Semlitsch,et al.  Perceptual and cognitive event-related potentials in neuropsychopharmacology: methodological aspects and clinical applications (pharmaco-ERP topography and tomography). , 2002, Methods and findings in experimental and clinical pharmacology.

[190]  D. Hubl,et al.  Multilead quantitative electroencephalogram profile and cognitive evoked potentials (P300) in healthy subjects after a single dose of olanzapine , 2001, Psychopharmacology.

[191]  Risto Näätänen,et al.  Effects of Haloperidol on Selective Attention A Combined Whole-Head MEG and High-Resolution EEG Study , 2001, Neuropsychopharmacology.

[192]  W. Pritchard,et al.  Effects of smoking/nicotine on performance and event-related potentials during a short-term memory scanning task , 2001, Psychopharmacology.

[193]  D. Tucker,et al.  Regulating action: alternating activation of midline frontal and motor cortical networks , 2001, Clinical Neurophysiology.

[194]  M. Botvinick,et al.  Conflict monitoring and cognitive control. , 2001, Psychological review.

[195]  T. Svensson,et al.  Reboxetine modulates the firing pattern of dopamine cells in the ventral tegmental area and selectively increases dopamine availability in the prefrontal cortex. , 2001, The Journal of pharmacology and experimental therapeutics.

[196]  E. Donchin,et al.  Spatiotemporal analysis of the late ERP responses to deviant stimuli. , 2001, Psychophysiology.

[197]  M. Bourin,et al.  Role of dopaminergic and serotonergic systems on behavioral stimulatory effects of low-dose alprazolam and lorazepam , 2001, European Neuropsychopharmacology.

[198]  D. Yurgelun-Todd,et al.  Biological Aspects of the Link between Smoking and Depression , 2000, Harvard review of psychiatry.

[199]  A. Arnsten,et al.  Genetics of childhood disorders: XVIII. ADHD, Part. 2: Norepinephrine has a critical modulatory influence on prefrontal cortical function. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[200]  A. Grace,et al.  The tonic/phasic model of dopamine system regulation and its implications for understanding alcohol and psychostimulant craving. , 2000, Addiction.

[201]  J. Buitelaar,et al.  Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate. , 2000, Psychophysiology.

[202]  A. Arnsten,et al.  Stress impairs prefrontal cortical function in rats and monkeys: role of dopamine D1 and norepinephrine α-1 receptor mechanisms , 2000 .

[203]  R. Knight,et al.  Neural origins of the P300. , 2000, Critical reviews in neurobiology.

[204]  B. Renault,et al.  Effects of Serotonin-Selective and Classical Antidepressants on the Auditory P300 Cognitive Potential , 1999, Neuropsychobiology.

[205]  Bao-Ming Li,et al.  Local infusion of an α-1 adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys , 1999, Biological Psychiatry.

[206]  Jonathan D. Cohen,et al.  Role of locus coeruleus in attention and behavioral flexibility , 1999, Biological Psychiatry.

[207]  S. Takashima,et al.  Developmental and age-related changes of dopamine transporter, and dopamine D1 and D2 receptors in human basal ganglia , 1999, Brain Research.

[208]  E. V. Van Bockstaele,et al.  Efferent projections of the nucleus of the solitary tract to peri‐locus coeruleus dendrites in rat brain: Evidence for a monosynaptic pathway , 1999, The Journal of comparative neurology.

[209]  Jimmy D Bell,et al.  Changes in Auditory Selective Attention and Event-Related Potentials Following Oral Administration of D-amphetamine in Humans , 1999, Neuropsychopharmacology.

[210]  Ulrich Hegerl,et al.  Neurochemical Substrates and Neuroanatomical Generators of the Event-Related P300 , 1999, Neuropsychobiology.

[211]  U. Schall,et al.  Effects of prepulses and d-amphetamine on performance and event-related potential measures on an auditory discrimination task , 1999, Psychopharmacology.

[212]  F. Bymaster,et al.  Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and α 1-adrenergic receptors in vitro , 1999, Schizophrenia Research.

[213]  A. Muzet,et al.  Electroencephalographic Characterization of Brain Dopaminergic Stimulation by Apomorphine in Healthy Volunteers , 1999, Neuropsychobiology.

[214]  A. Rivera,et al.  Differential regional and cellular distribution of dopamine D2‐like receptors: An immunocytochemical study of subtype‐specific antibodies in rat and human brain , 1998, The Journal of comparative neurology.

[215]  S. Preskorn,et al.  Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazodone, bupropion. , 1998, Journal of Affective Disorders.

[216]  J. Polich,et al.  P3a, perceptual distinctiveness, and stimulus modality. , 1998, Brain research. Cognitive brain research.

[217]  B. Yamamoto,et al.  Regulation of Extracellular Dopamine by the Norepinephrine Transporter , 1998, Journal of neurochemistry.

[218]  J. J. Lange,et al.  Color selection and location selection in ERPs: differences, similarities and `neural specificity' , 1998, Biological Psychology.

[219]  G F Potts,et al.  Dense sensor array topography of the event-related potential to task-relevant auditory stimuli. , 1998, Electroencephalography and clinical neurophysiology.

[220]  Allan I. Levey,et al.  Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter , 1998, The Journal of Neuroscience.

[221]  L. Giardino,et al.  Dopamine receptors in the striatum of rats exposed to repeated restraint stress and alprazolam treatment. , 1998, European journal of pharmacology.

[222]  R. Beninger,et al.  Dopamine D1-like Receptors and Reward-related Incentive Learning , 1998, Neuroscience & Biobehavioral Reviews.

[223]  Clay B. Holroyd,et al.  Error-related scalp potentials elicited by hand and foot movements: evidence for an output-independent error-processing system in humans , 1998, Neuroscience Letters.

[224]  R. Klorman,et al.  Methylphenidate's effects on paired-associate learning and event-related potentials of young adults. , 1998, Psychophysiology.

[225]  J. Polich.  P300 clinical utility and control of variability. , 1998, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[226]  J. Polich,et al.  Stimulus context determines P3a and P3b. , 1998, Psychophysiology.

[227]  M. Lader,et al.  Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine , 1998, Psychopharmacology.

[228]  E. Callaway,et al.  Effects of cotinine on information processing in nonsmokers , 1998, Psychopharmacology.

[229]  E K Perry,et al.  D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. , 1997, Pharmacogenetics.

[230]  M. Coles,et al.  Event-related potentials in a passive and active auditory condition: effects of diazepam and buspirone on slow wave positivity , 1997, Biological Psychology.

[231]  R. Davis,et al.  Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression. , 1997, Drugs.

[232]  Thomas J. H. Chen,et al.  Enhancement of Attention Processing by Kantroll™ in Healthy Humans: A Pilot Study , 1997, Clinical EEG.

[233]  E. French,et al.  Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra , 1997, Neuroreport.

[234]  R. Knight.  Contribution of human hippocampal region to novelty detection , 1996, Nature.

[235]  Gerald A. Hudgens,et al.  Salivary α‐amylase as a measure of endogenous adrenergic activity , 1996 .

[236]  M. Toussaint,et al.  Pharmacoelectroencephalographic profile of befloxatone, a new reversible MAO-A inhibitor, in healthy subjects. , 1996, Neuropsychobiology.

[237]  D. Accili,et al.  A new look at dopamine D3 receptors. , 1996, Molecular psychiatry.

[238]  G C Patton,et al.  Monitoring and care of young people at incipient risk of psychosis. , 1996, Schizophrenia bulletin.

[239]  R. Knight,et al.  Human prefrontal lesions increase distractibility to irrelevant sensory inputs , 1995, Neuroreport.

[240]  K. Meador,et al.  Comparative cognitive effects of phenobarbital, phenytoin, and valproate in healthy adults , 1995, Neurology.

[241]  D. Cohen,et al.  Acute and chronic effects of fluoxetine and haloperidol on mouse brain serotonin and norepinephrine turnover. , 1995, Life sciences.

[242]  C. Ogura,et al.  Effects of the dopamine‐related drug bromocriptine on event‐related potentials and its relation to the law of initial value , 1995, Psychiatry and clinical neurosciences.

[243]  L. Dratcu,et al.  A comparison of augmenting central serotonin and noradrenaline function in healthy subjects: implications for studies on the neurochemistry of anxiety , 1995, Journal of psychopharmacology.

[244]  D. Comings.  Tourette's syndrome: a behavioral spectrum disorder. , 1995, Advances in neurology.

[245]  J. Pineda.  Are neurotransmitter systems of subcortical origin relevant to the electrogenesis of cortical ERPs? , 1995, Electroencephalography and clinical neurophysiology. Supplement.

[246]  R. Verleger,et al.  Reduction of P3b in patients with temporo-parietal lesions. , 1994, Brain research. Cognitive brain research.

[247]  E Callaway,et al.  The effect of D-amphetamine, clonidine, and yohimbine on human information processing. , 1994, Psychophysiology.

[248]  C. Ogura,et al.  Effect of the dopamine D2 antagonist sulpiride on event-related potentials and its relation to the law of initial value. , 1994, International journal of psychophysiology : official journal of the International Organization of Psychophysiology.

[249]  C. Aoki,et al.  Perikaryal and synaptic localization of alpha 2A-adrenergic receptor-like immunoreactivity. , 1994, Brain research.

[250]  V. Jousmäki,et al.  Electrophysiological and neuropsychological effects of a central alpha2-antagonist atipamezole in healthy volunteers , 1993, Behavioural Brain Research.

[251]  R. Knight,et al.  Effects of temporal-parietal lesions on the somatosensory P3 to lower limb stimulation. , 1992, Electroencephalography and clinical neurophysiology.

[252]  J. Roth,et al.  Membrane-bound catechol-O-methyltransferase: a reevaluation of its role in the O-methylation of the catecholamine neurotransmitters. , 1992, Reviews of physiology, biochemistry and pharmacology.

[253]  Daniel Brandeis,et al.  Clonidine and scopolamine: Differences and similarities in how they change human information processing , 1991, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[254]  P. Stanzione,et al.  P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. , 1991, Electroencephalography and clinical neurophysiology.

[255]  S. Andrews,et al.  The effect of repeated testing on ERP components during auditory selective attention. , 1991, Psychophysiology.

[256]  J. Hohnsbein,et al.  Effects of crossmodal divided attention on late ERP components. II. Error processing in choice reaction tasks. , 1991, Electroencephalography and clinical neurophysiology.

[257]  G. Chiara,et al.  Blockade of the Noradrenaline Carrier Increases Extracellular Dopamine Concentrations in the Prefrontal Cortex: Evidence that Dopamine Is Taken up In Vivo by Noradrenergic Terminals , 1990, Journal of neurochemistry.

[258]  R. Knight,et al.  Contributions of temporal-parietal junction to the human auditory P3 , 1989, Brain Research.

[259]  N. Sitaram,et al.  The effect of clonidine on auditory P300 , 1989, Psychiatry Research.

[260]  J. Pineda,et al.  Effects of locus coeruleus lesions on auditory, long-latency, event- related potentials in monkey , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[261]  R. Näätänen.  Implications of ERP data for psychological theories of attention , 1988, Biological Psychology.

[262]  R. Klorman,et al.  Effects of methylphenidate on stimulus evaluation and response processes: evidence from performance and event-related potentials. , 1988, Psychophysiology.

[263]  S. Kish,et al.  Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications. , 1988, The New England journal of medicine.

[264]  J D Lewine,et al.  Does methylphenidate affect information processing? Findings from two studies on performance and P3b latency. , 1987, Psychophysiology.

[265]  A. Papanicolaou,et al.  Habituation of auditory event-related potentials: a comparison of self-initiated and automated stimulus trains. , 1987, Electroencephalography and clinical neurophysiology.

[266]  D. Woods,et al.  The habituation of event-related potentials to speech sounds and tones. , 1986, Electroencephalography and clinical neurophysiology.

[267]  V. B. Brooks,et al.  ‘Error’ potentials in limbic cortex (anterior cingulate area 24) of monkeys during motor learning , 1986, Neuroscience Letters.

[268]  F. Rösler,et al.  Delineation of pharmacopsychological effects by means of endogenous event-related brain potentials: an exemplification with flupentixol. , 1985, Neuropsychobiology.

[269]  J. Lewis,et al.  Effects of methylphenidate on young adults' performance and event-related potentials in a vigilance and a paired-associates learning test. , 1984, Psychophysiology.

[270]  R. Knight.  Decreased response to novel stimuli after prefrontal lesions in man. , 1984, Electroencephalography and clinical neurophysiology.

[271]  Y. Agid,et al.  Dopamine deficiency in the cerebral cortex in Parkinson disease , 1982, Neurology.

[272]  J. Glowinski,et al.  Reduction of dopamine utilization in the prefrontal cortex but not in the nucleus accumbens after selective destruction of noradrenergic fibers innervating the ventral tegmental area in the rat , 1982, Brain Research.

[273]  R. Carasso,et al.  Physiological evidence (hypothermia) for central effects of beta-blocker agents. , 1981, The International journal of neuroscience.

[274]  Masataka Watanabe,et al.  Prefrontal and cingulate unit activity during timing behavior in the monkey , 1979, Brain Research.

[275]  T. Brozoski,et al.  DOPAMINE IN PREFRONTAL CORTEX OF RHESUS MONKEYS: EVIDENCE FOR A ROLE IN COGNITIVE FUNCTION , 1979 .

[276]  A. Pfefferbaum,et al.  Vigilance and human attention under conditions of methylphenidate and secobarbital intoxication: an assessment using brain potentials. , 1978, Psychophysiology.

[277]  J. Walker,et al.  SELECTIVITY OF BLOCKING AGENTS FOR PRE‐ AND POSTSYNAPTIC α‐ADRENOCEPTORS , 1977 .

[278]  K. Starke,et al.  Preferential blockade of presynaptic α-adrenoceptors by yohimbine , 1975 .

[279]  B. K. Hartman,et al.  The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine‐B‐hydroxylase as a marker , 1975, The Journal of comparative neurology.

[280]  A. Guidotti,et al.  New concepts on the mechanism of action of benzodiazepines. , 1975, Life sciences.

[281]  E. John,et al.  Evoked-Potential Correlates of Stimulus Uncertainty , 1965, Science.

[282]  C. G. Ingram.  Some pharmacologic actions of yohimbine and chlorpromazine in man , 1962 .

[283]  G. Russell.  The nucleus locus coeruleus (dorsolateralis tegmenti). , 1955, Texas reports on biology and medicine.